Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 3/2013

01.03.2013 | Original Article

Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin

verfasst von: Kerstin Lorenz, Malik Elwerr, Andreas Machens, Mohammed Abuazab, Hans-Jürgen Holzhausen, Henning Dralle

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Calcitonin screening aims at uncovering occult medullary thyroid cancer (MTC) in patients with nodular thyroid disease. Elevated basal calcitonin serum levels call for calcitonin stimulation, the level of which may direct the extent of surgery. Because pentagastrin has become restricted, calcium has increasingly been used instead for stimulation. This study identified a new spectrum of patients demonstrating a false-positive hypercalcitoninemia in the absence of C-cell disease, carrying multinodular goiter (MNG), thyroiditis, and non-MTC thyroid malignancy, and endeavored to explore the feasibility of extrapolating pentagastrin-stimulated to calcium-stimulated calcitonin thresholds.

Methods

Altogether, 43 (9.5 %) of 455 patients with nodular thyroid disease revealed increased basal calcitonin serum levels between 2005 and 2012, for which they underwent intravenous stimulation with pentagastrin (31 patients) or calcium gluconate (12 patients) before and after primary thyroidectomy.

Results

Stimulation with calcium gluconate resulted in significantly higher and more variable preoperative calcitonin serum levels after 2 (241.2 vs. 104.9 pg/mL; P = 0.018) and 5 min (240.6 vs. 87.4 pg/mL; P = 0.007) than stimulation with pentagastrin. Stimulation with calcium gluconate produced 10-fold (nodular goiter), 15-fold (thyroiditis), and 21-fold (thyroid neoplasia other than MTC) calcitonin increases over baseline, as opposed to 5-fold, 10-fold, and 8-fold increases after stimulation with pentagastrin. None of the 43 patients, all of whom reverted to undetectable calcitonin serum levels after thyroidectomy, had immunohistochemical evidence of C-cell disease. Subgroup analyses according to gender and thyroid disease, being limited by the low number of patients in each subgroup, did not yield significant differences.

Conclusions

Calcium stimulation yields significantly greater calcitonin levels than pentagastrin stimulation, precluding generalization of pentagastrin-stimulated to calcium-stimulated calcitonin thresholds. After calcium stimulation, false-positive findings appear to be more common in patients of female gender and patients with thyroiditis and thyroid neoplasia other than MTC, potentially effecting surgical overtreatment.
Literatur
1.
Zurück zum Zitat Cohen R, Campos JM, Salaün C, Heshmati HM, Kraimps JL, Proye C, Sarfati E, Henry JF, Niccoli-Sire P, Modigliani E (2000) Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d’Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 85:919–922PubMedCrossRef Cohen R, Campos JM, Salaün C, Heshmati HM, Kraimps JL, Proye C, Sarfati E, Henry JF, Niccoli-Sire P, Modigliani E (2000) Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d’Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 85:919–922PubMedCrossRef
2.
Zurück zum Zitat Cooper CW, Schwesinger W, Ontjes D, Mahgoub A, Munson P (1971) Stimulation of secretion of pig thyrocalcitonin by gastrin and related hormonal peptides. Science 18:1238–1240CrossRef Cooper CW, Schwesinger W, Ontjes D, Mahgoub A, Munson P (1971) Stimulation of secretion of pig thyrocalcitonin by gastrin and related hormonal peptides. Science 18:1238–1240CrossRef
3.
Zurück zum Zitat Hennessy JF, Gray TK, Cooper CW, Ontjes DA (1973) Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in two patients with MTC. J Clin Endocrinol Metab 36:200–203PubMedCrossRef Hennessy JF, Gray TK, Cooper CW, Ontjes DA (1973) Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in two patients with MTC. J Clin Endocrinol Metab 36:200–203PubMedCrossRef
4.
Zurück zum Zitat Hennessy JF, Wells SA, Ontjes DA, Cooper CW (1974) A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of MTC. J Clin Endocrinol Metab 39:487–495PubMedCrossRef Hennessy JF, Wells SA, Ontjes DA, Cooper CW (1974) A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of MTC. J Clin Endocrinol Metab 39:487–495PubMedCrossRef
5.
Zurück zum Zitat Parthemore JG, Bronzert D, Roberts G, Deftos LJ (1974) A short calcium infusion in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab 39:108–111PubMedCrossRef Parthemore JG, Bronzert D, Roberts G, Deftos LJ (1974) A short calcium infusion in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab 39:108–111PubMedCrossRef
6.
Zurück zum Zitat Rude RK, Singer FR (1976) Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin in the diagnosis of MTC. J Clin Endocrinol Metab 44:980–983CrossRef Rude RK, Singer FR (1976) Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin in the diagnosis of MTC. J Clin Endocrinol Metab 44:980–983CrossRef
7.
Zurück zum Zitat Parthemore JG, Deftos LJ (1978) Calcitonin secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 49:223–226 Parthemore JG, Deftos LJ (1978) Calcitonin secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 49:223–226
8.
Zurück zum Zitat Wells SA, Baylin S, Gann D, Farrell R, Dilley W, Preissig S, Linehan WM, Cooper CW (1978) Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging. Ann Surg 188:377–383PubMedCrossRef Wells SA, Baylin S, Gann D, Farrell R, Dilley W, Preissig S, Linehan WM, Cooper CW (1978) Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging. Ann Surg 188:377–383PubMedCrossRef
9.
Zurück zum Zitat Doyle P, Düren C, Nerlich K, Verburg FA, Grelle I, Jahn H, Fassnacht M, Mäder U, Reiners C, Luster M (2009) Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. J Clin Endocrinol Metab 94:2970–2974PubMedCrossRef Doyle P, Düren C, Nerlich K, Verburg FA, Grelle I, Jahn H, Fassnacht M, Mäder U, Reiners C, Luster M (2009) Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. J Clin Endocrinol Metab 94:2970–2974PubMedCrossRef
10.
Zurück zum Zitat Kudo T, Miyauchi A, Ito Y, Yabuta T, Inoue H, Higashiyama T, Tomoda C, Hirokawa M, Amino N (2011) Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma. Endocr J 58:217–221PubMedCrossRef Kudo T, Miyauchi A, Ito Y, Yabuta T, Inoue H, Higashiyama T, Tomoda C, Hirokawa M, Amino N (2011) Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma. Endocr J 58:217–221PubMedCrossRef
11.
Zurück zum Zitat Colombo C, Verga U, Mian C, Ferrero S, Perrino M, Vicentini L, Dazzi D, Opocher G, Pelizzo MR, Beck-Peccoz P, Fugazzola L (2011) Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab 97:905–913PubMedCrossRef Colombo C, Verga U, Mian C, Ferrero S, Perrino M, Vicentini L, Dazzi D, Opocher G, Pelizzo MR, Beck-Peccoz P, Fugazzola L (2011) Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab 97:905–913PubMedCrossRef
12.
Zurück zum Zitat McLean GW, Rabin D, Moore L, Deftos LJ, Lorber D, McKenna TJ (1984) Evaluation of provocative test in suspected medullary carcinoma of the thyroid: heterogeneity of calcitonin responses to calcium and pentagastrin. Metabolism 33:790–796PubMedCrossRef McLean GW, Rabin D, Moore L, Deftos LJ, Lorber D, McKenna TJ (1984) Evaluation of provocative test in suspected medullary carcinoma of the thyroid: heterogeneity of calcitonin responses to calcium and pentagastrin. Metabolism 33:790–796PubMedCrossRef
13.
Zurück zum Zitat Erdoğan MF, Güllü S, Başkal N, Uysal AR, Kamel N, Erdoğan G (1997) Omeprazole: calcium stimulation test for the diagnosis, follow-up and screening of MTC. J Clin Endocrinol Metab 82:897–899PubMedCrossRef Erdoğan MF, Güllü S, Başkal N, Uysal AR, Kamel N, Erdoğan G (1997) Omeprazole: calcium stimulation test for the diagnosis, follow-up and screening of MTC. J Clin Endocrinol Metab 82:897–899PubMedCrossRef
14.
Zurück zum Zitat Vitale G, Ciccarelli A, Caraglia M, Galderisi M, Rossi R, Del Prete S, Abbruzzese A, Lupoli G (2002) Comparison of two provocative tests for calcitonin in MTC: omeprazole vs. pentagastrin. Clin Chem 48:1505–1510PubMed Vitale G, Ciccarelli A, Caraglia M, Galderisi M, Rossi R, Del Prete S, Abbruzzese A, Lupoli G (2002) Comparison of two provocative tests for calcitonin in MTC: omeprazole vs. pentagastrin. Clin Chem 48:1505–1510PubMed
15.
Zurück zum Zitat Cohen SL, MacIntyre I, Grahame-Smith D, Walker JG (1973) Alcohol-stimulated calcitonin release in MTC. Lancet 24:1172–1173CrossRef Cohen SL, MacIntyre I, Grahame-Smith D, Walker JG (1973) Alcohol-stimulated calcitonin release in MTC. Lancet 24:1172–1173CrossRef
16.
Zurück zum Zitat Wells SA Jr, Cooper CW, Ontjes DA (1975) Stimulation of thyrocalcitonin secretion by ethanol in patients with medullary thyroid carcinoma—an effect apparently not mediated by gastrin. Metabolism 24:1215–1219PubMedCrossRef Wells SA Jr, Cooper CW, Ontjes DA (1975) Stimulation of thyrocalcitonin secretion by ethanol in patients with medullary thyroid carcinoma—an effect apparently not mediated by gastrin. Metabolism 24:1215–1219PubMedCrossRef
17.
Zurück zum Zitat Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hüfner M, Niederle B, Brabant G (2004) Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112:52–58PubMedCrossRef Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hüfner M, Niederle B, Brabant G (2004) Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112:52–58PubMedCrossRef
18.
Zurück zum Zitat Toledo SP, Lourenço DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE (2009) Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clinics 64:699–706PubMedCrossRef Toledo SP, Lourenço DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE (2009) Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clinics 64:699–706PubMedCrossRef
19.
Zurück zum Zitat Pacini F, Schlumberger M, Dralle H, Ilisea R, Smith Y, Viersinga V (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 155:385–389CrossRef Pacini F, Schlumberger M, Dralle H, Ilisea R, Smith Y, Viersinga V (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 155:385–389CrossRef
20.
Zurück zum Zitat Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S (2005) Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15:1267–1272PubMedCrossRef Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S (2005) Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15:1267–1272PubMedCrossRef
21.
Zurück zum Zitat The International Agency for Research on Cancer, DeLellis R, Lloyd R, Heitz P, Eng C (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC, Lyon The International Agency for Research on Cancer, DeLellis R, Lloyd R, Heitz P, Eng C (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC, Lyon
22.
Zurück zum Zitat Gibelin H, Essique D, Jones C, Levillain P, Maréchaud R, Kraimps JL (2005) Increased calcitonin level in thyroid nodules without medullary carcinoma. Br J Surg 92:574–578PubMedCrossRef Gibelin H, Essique D, Jones C, Levillain P, Maréchaud R, Kraimps JL (2005) Increased calcitonin level in thyroid nodules without medullary carcinoma. Br J Surg 92:574–578PubMedCrossRef
23.
Zurück zum Zitat Palestini N, Borasi A, Cestino L, Freddi M, Odasso C, Robecchi A (2008) Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbeck's Arch Surg 393:693–698CrossRef Palestini N, Borasi A, Cestino L, Freddi M, Odasso C, Robecchi A (2008) Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbeck's Arch Surg 393:693–698CrossRef
24.
Zurück zum Zitat Wong KP, Lang BH (2011) The role of prophylactic central neck dissection in differentiated thyroid carcinoma: issues and controversies. J Oncol 127929 Wong KP, Lang BH (2011) The role of prophylactic central neck dissection in differentiated thyroid carcinoma: issues and controversies. J Oncol 127929
25.
Zurück zum Zitat Machens A, Dralle H (2012) Biological relevance of medullary thyroid microcarcinoma. J Clin Endocrinol Metab 97:1547–1553PubMedCrossRef Machens A, Dralle H (2012) Biological relevance of medullary thyroid microcarcinoma. J Clin Endocrinol Metab 97:1547–1553PubMedCrossRef
26.
Zurück zum Zitat Machens A, Hoffmann F, Sekulla C, Dralle H (2009) Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer 16:1291–1298PubMedCrossRef Machens A, Hoffmann F, Sekulla C, Dralle H (2009) Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer 16:1291–1298PubMedCrossRef
27.
Zurück zum Zitat Reubi JC, Schaer JC, Waser B (1997) Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res 57:1377–1386PubMed Reubi JC, Schaer JC, Waser B (1997) Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res 57:1377–1386PubMed
28.
Zurück zum Zitat Behr TM, Béhé MP (2002) Cholecystokinin-B/gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies. Semin Nucl Med 32:97–109PubMedCrossRef Behr TM, Béhé MP (2002) Cholecystokinin-B/gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies. Semin Nucl Med 32:97–109PubMedCrossRef
Metadaten
Titel
Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin
verfasst von
Kerstin Lorenz
Malik Elwerr
Andreas Machens
Mohammed Abuazab
Hans-Jürgen Holzhausen
Henning Dralle
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 3/2013
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-013-1049-6

Weitere Artikel der Ausgabe 3/2013

Langenbeck's Archives of Surgery 3/2013 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.